Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study

Gastroenterology. 1986 Apr;90(4):807-11. doi: 10.1016/0016-5085(86)90855-3.

Abstract

In a case-control study, we evaluated the relative risk of hepatic vein thrombosis among recent oral contraceptive users as compared with nonusers. Thirty-three cases of hepatic vein thrombosis affecting women aged 15-45 yr were collected between 1970 and 1983, and individually matched to 3 or 4 controls interviewed in 1982-1984. There were 18 recent oral contraceptive users among the 33 cases, and 44 recent oral contraceptive users among the 128 case-matched controls. The relative risk of hepatic vein thrombosis was 2.37 (95% confidence interval: 1.05-5.34, p less than 0.02). The relative risk of hepatic vein thrombosis is close to that of stroke, myocardial infarction, and venous thromboembolism among oral contraceptive users as compared with nonusers.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Budd-Chiari Syndrome / etiology*
  • Contraceptives, Oral / adverse effects*
  • Female
  • Humans
  • Middle Aged
  • Risk

Substances

  • Contraceptives, Oral